Breaking News Instant updates and real-time market news.

RARE

Ultragenyx

$85.02

6.37 (8.10%)

11:07
08/29/18
08/29
11:07
08/29/18
11:07

Ultragenyx filing allowance 'a clear step in right direction,' says JPMorgan

JPMorgan analyst Cory Kasimov said the announcement that UX007 can be filed for fatty acid oxidation disorders based primarily on Phase 2 data is "a clear step in the right direction" and he expects the news to help maintain the company's positive near-term momentum. FAOD could represent a billion-dollar-plus market, but Kasimov said he is maintaining his more conservative $300M peak sales forecast and 50% odds of success pending additional clarity on today's FDA filing allowance news. The analyst, who notes that Phase 3 data for UX007 in Glut1 DS, which is a potentially even larger market, is anticipated in the second half, keeps his Overweight rating on Ultragenyx shares.

  • 12

    Sep

  • 12

    Sep

RARE Ultragenyx
$85.02

6.37 (8.10%)

08/03/18
LEHM
08/03/18
NO CHANGE
Target $92
LEHM
Overweight
Ultragenyx price target raised to $92 from $74 at Barclays
Barclays analyst Gena Wang raised her price target for Ultragenyx to $92 saying the company for Q2 reported encouraging initial launch metrics for Crysvita in the U.S. The analyst sees multiple catalysts in the second half of 2018, including continued Crysvita commercial launch, clinical readouts from gene therapy programs DTX301 and DTX401, and regulatory feedback for UX007 in LC-FAOD. She reiterates an Overweight rating on Ultragenyx.
08/06/18
WEDB
08/06/18
NO CHANGE
Target $80
WEDB
Outperform
Ultragenyx price target raised to $80 from $71 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Ultragenyx to $80 from $71 after the company reported a solid start to Crysvita sales in the U.S., with rate of adult adoption and reimbursement particularly encouraging for potential growth opportunity. The analyst reiterates an Outperform rating on the shares.
08/20/18
RHCO
08/20/18
NO CHANGE
Target $83
RHCO
Buy
Ultragenyx price target raised to $83 from $69 at SunTrust
SunTrust analyst Edward Nash raised his price target on Ultragenyx to $83 and kept his Buy rating, saying the second half of 2018 should be "catalyst-rich" for the company. The analyst notes that he expects an E.U. approval for Mepsevii following a positive CHMP opinion along with two gene therapy programs, stating that these could be "significant value drivers" for the Ultragenyx stock.
08/29/18
PIPR
08/29/18
NO CHANGE
Target $89
PIPR
Overweight
Piper ups Ultragenyx target to $89 on 'surprise' UX007 filing acceptance
Piper Jaffray analyst Christopher Raymond raised his price target for Ultragenyx Pharmaceutical to $89 from $85 on news that FDA has accepted the company's proposal to submit for approval of UX007 in long-chain fatty acid oxidation disorders, based on existing data. The news pulls commercialization forward by upwards of one year plus, Raymond tells investors in a research note titled "Surprise, Surprise! FDA Appears Fine With Early Trihep FAOD Filing." He points out that management's overall tone on the potential for filing early was very cautious. The analyst thinks many investors will be surprised by today's development and that shares will react favorably. Raymond keeps an Overweight rating on Ultragenyx.

TODAY'S FREE FLY STORIES

HP

Helmerich & Payne

$67.61

0.34 (0.51%)

05:34
09/25/18
09/25
05:34
09/25/18
05:34
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHXM

DHX Media

$1.08

-0.11 (-9.24%)

, SNE

Sony

$56.86

-0.175 (-0.31%)

05:34
09/25/18
09/25
05:34
09/25/18
05:34
Hot Stocks
DHX Media concludes strategic review »

DHX Media (DHXM)…

DHXM

DHX Media

$1.08

-0.11 (-9.24%)

SNE

Sony

$56.86

-0.175 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ASC

Ardmore Shipping

$6.90

-0.05 (-0.72%)

05:33
09/25/18
09/25
05:33
09/25/18
05:33
Upgrade
Ardmore Shipping rating change  »

Ardmore Shipping upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

CENT

Central Garden & Pet

$38.28

-0.95 (-2.42%)

05:30
09/25/18
09/25
05:30
09/25/18
05:30
Initiation
Central Garden & Pet initiated  »

Central Garden & Pet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DFIN

Donnelley Financial Solutions

$20.78

0.19 (0.92%)

05:27
09/25/18
09/25
05:27
09/25/18
05:27
Downgrade
Donnelley Financial Solutions rating change  »

Donnelley Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$207.30

2.25 (1.10%)

05:26
09/25/18
09/25
05:26
09/25/18
05:26
Hot Stocks
Amgen announces approval for Blincyto in Japan »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

  • 22

    Oct

  • 09

    Nov

SAIC

SAIC

$78.88

-0.59 (-0.74%)

, EGL

Engility

$35.14

-0.12 (-0.34%)

05:23
09/25/18
09/25
05:23
09/25/18
05:23
Upgrade
SAIC, Engility rating change  »

SAIC upgraded to Buy from…

SAIC

SAIC

$78.88

-0.59 (-0.74%)

EGL

Engility

$35.14

-0.12 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLR

Digital Realty

$115.95

-5.055 (-4.18%)

05:19
09/25/18
09/25
05:19
09/25/18
05:19
Syndicate
Digital Realty 8.5M share Secondary priced at $113.00 »

BofA/Merrill and Citi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 04

    Oct

  • 22

    Oct

  • 25

    Sep

SQ

Square

$86.06

0.75 (0.88%)

, FB

Facebook

$165.40

2.5 (1.53%)

05:18
09/25/18
09/25
05:18
09/25/18
05:18
Recommendations
Square, Facebook, Alphabet, Alphabet Class A, Amazon.com, Netflix analyst commentary  »

Square price target…

SQ

Square

$86.06

0.75 (0.88%)

FB

Facebook

$165.40

2.5 (1.53%)

GOOG

Alphabet

$1,173.38

7.17 (0.61%)

GOOGL

Alphabet Class A

$1,179.78

7.56 (0.64%)

AMZN

Amazon.com

$1,934.50

16.75 (0.87%)

NFLX

Netflix

$369.70

8.71 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 13

    Nov

  • 26

    Nov

  • 03

    Mar

VIOT

Viomi Technology

$0.00

(0.00%)

05:18
09/25/18
09/25
05:18
09/25/18
05:18
Syndicate
Viomi Technology 11.4M share IPO priced at $9.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

VCTR

Victory Capital

$9.50

0.45 (4.97%)

05:12
09/25/18
09/25
05:12
09/25/18
05:12
Upgrade
Victory Capital rating change  »

Victory Capital upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

  • 10

    Oct

IRET

Investors Real Estate

$5.58

-0.03 (-0.53%)

05:11
09/25/18
09/25
05:11
09/25/18
05:11
Upgrade
Investors Real Estate rating change  »

Investors Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCCI

Heritage-Crystal Clean

$20.40

-0.15 (-0.73%)

05:10
09/25/18
09/25
05:10
09/25/18
05:10
Upgrade
Heritage-Crystal Clean rating change  »

Heritage-Crystal Clean…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 01

    Oct

GHDX

Genomic Health

$70.84

1.65 (2.38%)

, LH

LabCorp

$169.54

-2.46 (-1.43%)

05:09
09/25/18
09/25
05:09
09/25/18
05:09
Recommendations
Genomic Health, LabCorp, Myriad Genetics, Natera, Quest Diagnostics analyst commentary  »

Piper sees early winners…

GHDX

Genomic Health

$70.84

1.65 (2.38%)

LH

LabCorp

$169.54

-2.46 (-1.43%)

MYGN

Myriad Genetics

$46.91

0.64 (1.38%)

NTRA

Natera

$23.83

-0.35 (-1.45%)

DGX

Quest Diagnostics

$107.61

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

  • 27

    Nov

WK

Workiva

$37.20

0.65 (1.78%)

05:08
09/25/18
09/25
05:08
09/25/18
05:08
Upgrade
Workiva rating change  »

Workiva upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CY

Cypress Semiconductor

$15.52

-0.45 (-2.82%)

05:07
09/25/18
09/25
05:07
09/25/18
05:07
Downgrade
Cypress Semiconductor rating change  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLAR

Clarus Corporation

$10.45

-0.3 (-2.79%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Clarus Corporation management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AMSC

AMSC

$6.33

-0.265 (-4.02%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AMSC management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

NNBR

NN, Inc.

$15.65

-0.05 (-0.32%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
NN, Inc. to host two day investor day »

Two day investor day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

LBTYA

Liberty Global

$28.37

-0.87 (-2.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Liberty Global management to meet with Wolfe Research »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

TRU

TransUnion

$73.68

-0.62 (-0.83%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TransUnion management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 23

    Oct

TSLX

TPG Specialty Lending

$20.56

-0.15 (-0.72%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TPG Specialty Lending management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

THR

Thermon Group

$25.98

-0.14 (-0.54%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Thermon Group management to meet with William Blair »

Group luncheon with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

04:55
09/25/18
09/25
04:55
09/25/18
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

September Richmond Fed…

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AdvaMed to hold a conference »

MedTech Conference will…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.